drugset / Trial / NCT01952782

Neuropeptides in Human Reproduction

NCT01952782

Phase 1 Completed 61 enrolled Massachusetts General Hospital
NaSingle-groupOpen-labelOther

Summary

The investigators are seeking healthy volunteers and volunteers with reproductive disorders for the study of the role of dynorphin in the reproductive system. Dynorphin is a naturally occurring opioid hormone that is blocked by naloxone. We hypothesize that naloxone, by blocking dynorphin, will stimulate production of gonadotropin-releasing hormone (GnRH) and kisspeptin, two other naturally occurring reproductive hormones.

Timeline

Start
2014-04-30
Primary completion
2016-05-31
Completion
2016-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Gonadorelin Protein / enzyme biologic Intravenous
Subject Naloxone Small molecule Intravenous
Subject kisspeptin 112-121 Peptide Intravenous